EU regulators recommend suspending access to Indian drug data
-
Last Update: 2015-01-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: DXY 2015-01-26 European drug regulatory agency said on 23 this month that it has proposed to suspend the clinical research of several drugs carried out by GVK Biosciences in Hyderabad, India The European Medicines Agency said the proposal was based on the results of some tests, fearing that GVK was a study conducted in Hyderabad on behalf of pharmaceutical companies As a result, regulators in France, Germany, Belgium and Luxembourg suspended 25 generic approval projects in December for fear of the reliability of clinical trial data from Indian companies
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
